Deeptek.ai: Revolutionizing Radiology with AI-Powered Precision and Accessibility

Deeptek.ai is a pioneering medical imaging AI company based in Pune, India, dedicated to transforming radiology by making quality, accurate, and affordable imaging services accessible across clinical and public health settings. With a suite of FDA-cleared and CE MDR-certified AI tools, Deeptek.ai empowers hospitals, diagnostic centers, and public health programs—especially in underserved regions—with intelligent automation, real-time diagnostics, and seamless integration into existing workflows. The platform excels in chest X-ray analysis for tuberculosis and COVID-19 screening, delivering high accuracy and rapid results even in offline environments, while supporting multi-modality imaging and advanced analytics for continuous monitoring and performance optimization.

Key Features:

• Chest X-ray AI for TB & COVID-19 Screening: High-precision detection of over 21 lung abnormalities, including nodules, masses, and pneumothorax.
• Augmento Enterprise & Lite Platforms: AI deployment platforms with cloud PACS capabilities, supporting multi-center, multi-stakeholder workflows.
• AI Triaging & Scan Segregation: Automatically categorizes chest X-rays into low- and high-suspicion groups with high accuracy.
• Structured Clinical Report Generation: Produces standardized, actionable reports to streamline radiologist workflow.
• Agentic AI-Powered Diagnostic Reporting: Enables intelligent, automated diagnostic insights and teleradiology support.
• Explainable AI: Features heatmaps, bounding boxes, and outlines to visualize AI findings for transparency and trust.
• Real-Time Analytics & Dashboards: Offers comprehensive, customizable insights for program coordinators and radiologists.
• Multi-Modality Scan Processing: Handles over 100,000 scans per month across CT, MR, PET-CT, and X-ray modalities.
• Seamless System Integration: Works with existing HIS, RIS, and PACS systems, both on-premise and in the cloud.
• Mobile App & AI Bot: Accessible tools via the Resources Hub for on-the-go diagnostics and support.
• Edge & Cloud Deployment: Genki-Edge enables offline operation in remote or low-connectivity areas.
• Regulatory Compliance: Holds US FDA clearance, CE MDR Class IIb certification, CDSCO, HSA, Thai FDA, Kenya Board, and GDPR/HIPAA compliance.
• Continuous Accuracy Monitoring: Tracks real-world performance to detect AI drift, bias, or effectiveness changes.
• Public Health Program Support: Deployed in mobile diagnostic units and national screening initiatives (e.g., Greater Chennai Corporation, Synapxe in Singapore).
• Global Reach: Operational in India, APAC, Thailand, Mongolia, Philippines, Tunisia, Indonesia, and Kenya.
• Research-Backed Innovation: Published 29+ research papers in journals like Nature Scientific Reports, Elsevier, and medRxiv; validated in independent studies.

Pricing: Deeptek.ai offers flexible solutions with a freemium model, allowing access to foundational AI tools and resources for initial evaluation and small-scale use, while advanced platforms like Augmento Enterprise are available through subscription and enterprise licensing.

Conclusion: Deeptek.ai stands at the forefront of medical AI innovation, combining clinical-grade accuracy with scalable deployment for both hospitals and public health programs. Its WHO-recommended, globally certified solutions are making a tangible impact—processing millions of scans, improving diagnostic speed and yield, and expanding access to life-saving radiology services worldwide.